NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/09/2024
Voltar para busca
Dado oficial do USPTO
LAVA THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LAVA THERAPEUTICS
ST13
US500000079354142Classe
1, 5, 42, 44
Pedido
79354142
Registro
7238557
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
28/09/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
24/09/2021
Data de registro
12/12/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/12/2023
Última transação
12/12/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
NL
Examinador
PATEL, SAMIR
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Lava Therapeutics N.V.
Representantes
Robert R. Baron, Jr. Ballard Spahr LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Antibodies for scientific and research use; libraries of antibodies and collections of antibodies for scientific and research use; proteinsenzymesdiagnostic reagents for scientific and research usechemical and biochemical preparations and substances for use in the manufacture of medicines
Classe 5
Pharmaceutical preparations for T-Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy productspharmaceutical preparations for the treatment of cancerautoimmune diseasesimmunological disorders; biological preparations for the treatment of cancer autoimmune diseasesimmunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancerautoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposesfor treatment and/or diagnosis of cancerautoimmune diseases and immunological disorders
Classe 42
Bio-technology and scientific servicesresearch and development services relating to bio-technology and science in the field of antibodiesproteins and enzymes; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research servicesantibodies evolving servicesprotein evolving services and enzyme evolving services; biochemistry research servicesantibodiesprotein and enzyme cataloging and antibodiesprotein and enzyme library services; laboratory research and medical laboratory testing services relating to the production of antibodiesproteins and enzymes
Classe 44
Providing medical information about the treatment and/or diagnosis of cancerautoimmune diseases and immunological disorders via a website
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/04/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/03/2024
FIMP
FINAL DISPOSITION PROCESSED
14/03/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/09/2023
PUBO
PUBLISHED FOR OPPOSITION
26/09/2023
GPNX
NOTIFICATION PROCESSED BY IB
25/09/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/09/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/09/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/09/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
22/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/04/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
17/03/2023
RFNT
REFUSAL PROCESSED BY IB
15/02/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/01/2023
RFRR
REFUSAL PROCESSED BY MPU
20/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/01/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/11/2022
CNRT
NON-FINAL ACTION WRITTEN
12/11/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2022
DOCK
ASSIGNED TO EXAMINER
04/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/11/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LAVA THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.